LeafNLP Demos
Back to explore

Report #2870333

Received Nov 3, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
MI
Recovered
Unknown
Vaccinated
Oct 20, 2025
Onset
Oct 20, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS393N4J—

Symptoms (1)

Extra dose administered

Symptom narrative

Shingrix plus third dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 59-year-old female patient who received Herpes zoster (Shingrix) (batch number 93N4J, expiry date 25-APR-2027) for prophylaxis. Previously administered products included Shingrix (received 1st dose on unknown date) and Shingrix (received 2nd dose on unknown date). On 20-OCT-2025, the patient received the 3rd dose of Shingrix. On 20-OCT-2025, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: Shingrix plus third dose). The outcome of the extra dose administered was not applicable. Additional Information: GSK receipt date: 20-OCT-2025 Reporter stated a third dose of Shingrix was given inadvertently to a patient, reporter stated patient did not had a reaction. The batch number was not provided and a request for this information has been made.